Topic

Humana

A collection of 126 issues

How to Get Besponsa (Inotuzumab Ozogamicin) Covered by Humana in North Carolina: Complete Guide to Prior Authorization, Appeals, and Billing Codes

Answer Box: Getting Besponsa Covered by Humana in North Carolina Besponsa (inotuzumab ozogamicin) requires prior authorization through Evolent/New Century Health for all Humana Medicare Advantage plans. Submit requests via their portal at my.newcenturyhealth.com or call 844-926-4528 (option 5). Required documentation includes CD22-positive B-cell ALL diagnosis (ICD-10: C91.
6 min read

How to Get Evkeeza (Evinacumab-dgnb) Covered by Humana in New York: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Evkeeza Covered by Humana in New York Evkeeza (evinacumab-dgnb) is covered by Humana Medicare Advantage plans but requires prior authorization. For fastest approval: (1) Your provider submits genetic testing results confirming homozygous familial hypercholesterolemia (HoFH), documented LDL-C levels >400-500 mg/dL, and records of maximally tolerated
6 min read

Renewing Emgality (galcanezumab-gnlm) Approval with Humana in North Carolina: Timeline, Documents & Bridge Options

Answer Box: Renewing Emgality Coverage with Humana in North Carolina Start your renewal 30 days before expiration to avoid therapy gaps. Humana requires updated headache diaries showing continued benefit, provider documentation of ongoing medical necessity, and submission through their Clinical Pharmacy Review portal. If denied, North Carolina residents can appeal
6 min read

How to Get Soliris (Eculizumab) Covered by Humana in Pennsylvania: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Soliris (Eculizumab) Covered by Humana in Pennsylvania Yes, Humana covers Soliris (eculizumab) in Pennsylvania, but requires strict prior authorization. The medication typically falls under Tier 5 (specialty tier) with 25-33% coinsurance. Your fastest path to approval: 1) Ensure meningococcal vaccination is completed at least 2 weeks before
7 min read